BG102015A - Azacycloalkane derivatives, their preparation and application in therapy - Google Patents

Azacycloalkane derivatives, their preparation and application in therapy

Info

Publication number
BG102015A
BG102015A BG102015A BG10201597A BG102015A BG 102015 A BG102015 A BG 102015A BG 102015 A BG102015 A BG 102015A BG 10201597 A BG10201597 A BG 10201597A BG 102015 A BG102015 A BG 102015A
Authority
BG
Bulgaria
Prior art keywords
radical
hydrogen atom
preparation
application
bound
Prior art date
Application number
BG102015A
Other languages
Bulgarian (bg)
English (en)
Inventor
Zurita Manuel Bedoya
Martin Juan Diaz
Sol Moreno Gregorio Del
Perez Ulpiano Martin-Escudero
Bargueno Maria Jimenez
Ferrer Magali Romanach
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of BG102015A publication Critical patent/BG102015A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BG102015A 1995-05-03 1997-11-03 Azacycloalkane derivatives, their preparation and application in therapy BG102015A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9505260A FR2733750B1 (fr) 1995-05-03 1995-05-03 Derives de l'acide gamma-oxo-alpha-(phenylmethyl)-5,6- dihydro-4h-thieno(3,4-c)pyrrole-5-butanoique, leur preparation et leur application en therapeutique
PCT/FR1996/000555 WO1996034870A1 (fr) 1995-05-03 1996-04-12 Derives d'azacycloalcanes, leur preparation et leurs applications en therapeutique

Publications (1)

Publication Number Publication Date
BG102015A true BG102015A (en) 1998-08-31

Family

ID=9478644

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102015A BG102015A (en) 1995-05-03 1997-11-03 Azacycloalkane derivatives, their preparation and application in therapy

Country Status (22)

Country Link
US (1) US5869518A (fr)
EP (1) EP0823912A1 (fr)
JP (1) JPH11504913A (fr)
KR (1) KR19990008276A (fr)
AR (1) AR001838A1 (fr)
AU (1) AU699120B2 (fr)
BG (1) BG102015A (fr)
BR (1) BR9608309A (fr)
CA (1) CA2220015A1 (fr)
CO (1) CO4750652A1 (fr)
CZ (1) CZ346697A3 (fr)
EE (1) EE9700288A (fr)
FR (1) FR2733750B1 (fr)
HU (1) HUP9903886A3 (fr)
IL (1) IL118119A0 (fr)
NO (1) NO975020L (fr)
NZ (1) NZ307230A (fr)
PL (1) PL323177A1 (fr)
SK (1) SK147897A3 (fr)
TR (1) TR199701287T1 (fr)
WO (1) WO1996034870A1 (fr)
ZA (1) ZA963485B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998040385A1 (fr) * 1997-03-07 1998-09-17 Novo Nordisk A/S DERIVES DE 4,5,6,7-TETRAHYDRO-THIENO[3,2-c]PYRIDINE, LEUR PREPARATION ET LEUR UTILISATION
US6177443B1 (en) 1997-03-07 2001-01-23 Novo Nordisk A/S 4,5,6,7-tetrahydro-thieno[3, 2-C]pyridine derivatives, their preparation and use
WO1999045013A1 (fr) * 1998-03-06 1999-09-10 Novo Nordisk A/S Derives de 4,5,6,7-tetrahydro-thieno[3,2-c]pyridine
FR2777566B1 (fr) 1998-04-15 2003-02-21 Synthelabo Derives d'azacycloalcanes, leur preparation et leur application en therapeutique
FR2779428B1 (fr) * 1998-06-03 2001-05-18 Synthelabo Derives d'oxo-azacycloalcanes, leurs preparations et leurs applications en therapeutique
AU5154699A (en) * 1998-09-02 2000-03-27 Novo Nordisk A/S 4,5,6,7-tetrahydro-thieno(2,3-c)pyridine derivatives
US6090797A (en) * 1998-09-02 2000-07-18 Novo Nordisk A/S 4,5,6,7-tetrahydro-thieno(2,3-C)pyridine derivatives
FR2793411B1 (fr) * 1999-05-11 2001-06-29 Synthelabo Utilisation de derives de l'acide succinique pour obtenir un medicament destine au traitement de l'inflammation
PT1088824E (pt) * 1999-09-30 2004-04-30 Pfizer Prod Inc Pirrolil-amidas biciclicas como inibidores de glicogenio-fosforilase
US6797820B2 (en) 1999-12-17 2004-09-28 Vicuron Pharmaceuticals Inc. Succinate compounds, compositions and methods of use and preparation
AR036053A1 (es) 2001-06-15 2004-08-04 Versicor Inc Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas
WO2002102791A1 (fr) * 2001-06-15 2002-12-27 Vicuron Pharmaceuticals Inc. Composés bicycliques de pyrrolidine
US20090312470A1 (en) * 2008-06-11 2009-12-17 Ferro Corporation Asymmetric Cyclic Diester Compounds
US20100113664A1 (en) * 2008-06-11 2010-05-06 Ferro Corporation Asymmetric Cyclic Diester Compounds
DK2350093T3 (da) * 2008-10-24 2012-11-12 Gruenenthal Gmbh Substituerede 4,5,6,7-tetrahydrothienopyridiner som KCNQ2/3-modulatorer til behandling af smerte, epilepsi og urininkontinens.
US9302989B2 (en) 2010-11-15 2016-04-05 Abbvie Inc. NAMPT and rock inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3190950A (en) * 1961-03-13 1965-06-22 Acf Ind Inc Pictorial position display
US3706810A (en) * 1970-09-15 1972-12-19 American Cyanamid Co N-morpholinoalkyl-thieno(3,2-b)pyrrole-5-carboxamides
ZA821020B (en) * 1981-02-18 1983-10-26 Thomae Gmbh Dr K Azepine derivatives, process for their preparation and pharmaceutical compositions thereof
FR2537974A1 (fr) * 1982-12-16 1984-06-22 Adir Nouveaux derives de thieno (2,3-b) pyrrole, leur procede de preparation et les compositions pharmaceutiques les renfermant
FR2571723B1 (fr) * 1984-10-12 1988-08-26 Lipha Derives de thieno et furo-(2,3-c) pyrroles, procedes de preparation et medicaments les contenant
FR2652579B1 (fr) * 1989-10-02 1992-01-24 Sanofi Sa Derives d'hydroxy-2 thiophene et furanne condenses avec un cycle azote, sur procede de preparation et leur application en therapeutique.
FR2676446B1 (fr) * 1991-05-17 1993-08-06 Rhone Poulenc Rorer Sa Nouveaux derives du thiopyranopyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent.
EP0599697A1 (fr) * 1992-11-24 1994-06-01 Synthelabo Dérivés de pyrrole, leur préparation et leur application en thérapeutique
FR2719844B1 (fr) * 1994-05-10 1996-06-07 Synthelabo Dérivés de 5,6-dihydro-4h-thiéno[3,4-c]pyrrole, leur préparation et leur application en thérapeutique.

Also Published As

Publication number Publication date
US5869518A (en) 1999-02-09
FR2733750A1 (fr) 1996-11-08
AU699120B2 (en) 1998-11-19
TR199701287T1 (xx) 1998-03-21
IL118119A0 (en) 1996-09-12
CO4750652A1 (es) 1999-03-31
PL323177A1 (en) 1998-03-16
HUP9903886A2 (hu) 2000-03-28
FR2733750B1 (fr) 1997-06-13
EE9700288A (et) 1998-04-15
JPH11504913A (ja) 1999-05-11
NZ307230A (en) 1998-11-25
KR19990008276A (ko) 1999-01-25
BR9608309A (pt) 1999-01-26
WO1996034870A1 (fr) 1996-11-07
ZA963485B (en) 1996-11-25
HUP9903886A3 (en) 2000-04-28
AU5652096A (en) 1996-11-21
NO975020D0 (no) 1997-10-31
MX9708322A (es) 1998-06-28
CA2220015A1 (fr) 1996-11-07
NO975020L (no) 1998-01-05
EP0823912A1 (fr) 1998-02-18
CZ346697A3 (cs) 1998-02-18
AR001838A1 (es) 1997-12-10
SK147897A3 (en) 1998-05-06

Similar Documents

Publication Publication Date Title
BG102015A (en) Azacycloalkane derivatives, their preparation and application in therapy
NZ333586A (en) Anticonvulsant sulfamate derivatives, preferably topiramate, useful in treating obesity
DK0652005T3 (da) Fremgangsmåder til inhibering af endometriose
IL111288A0 (en) Methods for inhibiting smooth muscle cell proliferation and restinosis
AP9701039A0 (en) Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one.
NZ332658A (en) Halo-substituted bis-indolylmaleimide derivatives and pharmaceutical compositions
MX9701329A (es) Metodos para la inhibicion de la replicacion viral.
MX9701325A (es) Metodos para inhibir la mucositis ulcerativa.
DK0652004T3 (da) Fremgangsmåder til behandling af resistente neoplasmer
UA27910C2 (uk) Засіб для підвищення експресії тромбомодуліну та підвищення активації протеїну с
HU9601217D0 (en) Antracyclinone derivatives and their use for treating amyloidosis
MX9701334A (es) Metodos para inhibir la degeneracion de protesis oseas.
MX9709466A (es) Medicamento para inhibir el melanoma.
EA199900910A1 (ru) Профилактика рака молочной железы селективными модуляторами рецепторов эстрогена
ZA962037B (en) 17-difluoromethylene-estratriene
MX9701327A (es) Metodos para inhibir el cancer endometrial.
MX9702148A (es) Metodos para inhibir la mitosis endometrial.
MX9804255A (es) Ditiazoldioxidos y su uso como microbicidas.
BG105247A (en) N-substituted azabicycloheptane derivatives, production and use thereof
TR200001976T2 (tr) İzopropil-Metil [2-(3-n-propoksifenoksi)etil] amin'in hazırlanmasına yönelik usul
ES8707939A1 (es) Procedimiento para preparar derivados de n-carboxialquil-2--oxo-3-diaril-5,6-triazinas
MX9701331A (es) Metodos para mantener los dientes y los huesos bucales.
MX9706520A (es) Metodos para inhibir el cancer de ovario.
MX9701359A (es) Metodos para la inhibicion de la hiperplasia endometrial primaria.
MX9705697A (es) Metodos para reducir los niveles de calcio del suero.